from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2377c/mbtH

LFCtreatmentdescriptionclass of inhibitor

-0.575

Amikacinug/mL Amikacintranslation

-0.647

Cap5-10ug/mL Capreomycintranslation

-0.695

Rox10-50 ug/mL Roxithromycintranslation

-1.258

SM2-5 ug/mL Streptomycintranslation

-1.774

Tet5-10 ug/mL Tetracyclinetranslation

-0.544

Rif0.2-5ug/mL Rifampicintranscription

-0.135

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.076

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.146

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.214

CPZ10-50 ug/mL Chlorpromazinerespiration

3.442

Clofazimine10-13 ug/mL Clofaziminerespiration

0.097

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.202

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.473

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.224

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.164

Econazole10-24 ug/mL Econazole (azole drug)respiration

3.394

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.165

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.466

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.651

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.722

KCN5-20 ug/mL Potassium cyaniderespiration

0.229

NaN30.2-2 mM Sodium aziderespiration

-0.244

Nigericin50 uM Nigericinrespiration

0.136

TRC10-150 ug/mL Triclosanrespiration

-0.366

TRZ10-25 ug/mL Thioridazinerespiration

-0.282

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.105

menadione6-10 ug/mL Menadionerespiration

2.539

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.553

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.839

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.769

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.837

NRP_1Non-replicating persistence stage 1dosRassociated

-0.225

Amp0.2mg/mL AmpicillincellWall

-0.091

Cephalexin20-100 ug/mL CephalexincellWall

-0.006

Cerulenin0.32-5 ug/mL CerulenincellWall

0.059

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.257

EMB10-20 ug/mL EthambutolcellWall

0.193

Eta12-40 ug/mL EthionamidecellWall

0.003

INH0.2-0.4 ug/mL IsoniazidcellWall

0.178

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.410

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.942

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.292

BZA0.12 mg/mL BenzamidearomaticAmides

-0.378

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.361

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.148

Levo10 ug/mL LevofloxacinDNAdamaging

-0.242

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.106

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.227

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.272

UVUV-irradiationDNAdamaging

0.535

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.223

Antimycin12.5-50 ug/mL Antimycin A?

-0.175

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

0.215

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.470

PA8240.2-2 ug/mL PA-824?

-0.355

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.135

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.141

Verapamil50 uM Verapamil?

0.166

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.261

methoxatin10-20 ug/mL Methoxatin?